Summary

ILiAD Biotechnologies LLC

Founded in 2012

Description

ILiAD is developing the leading next generation vaccine for the prevention of #WhoopingCough, a serious illness caused by Bordetella #pertussis.

Strengths

  • Revenue growth is more steady than the industry average
  • Since ILiAD Biotechnologies LLC was founded, the company has grown faster than the industry average

Weaknesses

  • ILiAD Biotechnologies LLC has a very small market share in their industry
  • Revenue generated per employee is less than the industry average
  • Revenue growth is less than the industry average
  • The number of employees is not growing as fast as the industry average

Annual Revenue

ILiAD Biotechnologies LLC's annual revenue

$4102000

Based on Kona Equity data

  • Revenue per employee

    $315538

  • Variance of revenue growth

    0.06

  • Annual revenue growth since founding

    $341833

  • Revenue growth rate from first known quarter to current

    -16.5%

Employee Count

13 employees

  • Employee growth rate from first known quarter to current

    -11.5%

Executives

Ken Solovay

Chief Operating Officer

k**@iliadbio.com

Jim Ramadei

Controller

j**@iliadbio.com

Luis Nogales

Executive Vice President & Chief Development Officer

l**@iliadbio.com

Stephanie Noviello

Chief Medical Officer

s**@iliadbio.com

Peter Goldstein

Senior Director

p**@iliadbio.com

Keith Rubin

CEO

k**@iliadbio.com

Matthew Bross

Administrative Manager

m**@iliadbio.com

Steve Glazer

Director, Research Programs

s**@iliadbio.com

Phone Biotechnologies

Founder & Chief Executive Officer

p**@iliadbio.com

Avi Naider

Board Member

a**@iliadbio.com

G Score - 2

The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.

  • G5 Variance of revenue growth is less than the industry average
  • G6 Annual revenue growth since founding is higher than the industry average.

Location

230 East 15th St. Ste. 1-A 
New York City, NY  10003

Unlock unlimited leads

Get access to millions of contacts, companies, emails, and more!

Similar Companies

DepYmed Inc

depymedinc.com
  • Founded in 2014
  • Location: Farmingdale, NY
  • Annual Revenue: $2.2M
  • Employees: 8
  • DepYmed is a pharmaceutical company that specializes in developing potent inhibitors of the enzyme PTP1B for the treatment of various diseases, including Rett Syndrome, Wilson Disease, and cancer. They also have a portfolio of novel small molecules wit...

Applied Therapeutics

appliedtherapeutics.com
  • Founded in 2016
  • Location: New York City, NY
  • Annual Revenue: $9.1M
  • Employees: 27
  • Applied Therapeutics is a clinical stage biopharmaceutical company that uses our novel drug development approach to create transformative, life changing treatments for the patients who desperately need them. Biotechnology Research

CuraVac

curavac.com
  • Founded in 2003
  • Location: Wilmington, DE
  • Annual Revenue: $1.3M
  • Employees: 5

CNS Pharmaceuticals , Inc.

cnspharma.com
  • Founded in 2017
  • Location: Houston, TX
  • Annual Revenue: $1.7M
  • Employees: 3
  • CNS Pharmaceuticals is a biotechnology company specializing in the development of novel treatments for brain tumors. CNS Pharmaceuticals is developing novel treatments for primary and metastatic cancers of the brain and central nervous system. Its lead...

Cartesian Therapeutics

cartesiantherapeutics.com
  • Founded in 2016
  • Location: Gaithersburg, MD
  • Annual Revenue: $4.2M
  • Employees: 15
  • Cartesian Therapeutics is a fully integrated, clinical stage biopharmaceutical company developing novel cell and gene immunotherapies to treat cancer and autoimmune diseases.

Resolve Therapeutics

resolvebio.com
  • Location: Seattle, WA
  • Annual Revenue: $2.8M
  • Employees: 14

Key Information

  • SIC: 283; 28
  • NAICS: 5417; 541
Disclaimer: These numbers are estimates and any other company information is based off our proprietary algorithms and by no means should be accepted as 100% factual. Kona Equity is in no way affiliated with ILiAD Biotechnologies LLC.

See similar companies

Frequently Asked Questions

Where is ILiAD Biotechnologies LLC located?

ILiAD Biotechnologies LLC's headquarters are located at 230 East 15th St. Ste. 1-A  New York City, NY  10003.


What is ILiAD Biotechnologies LLC's official website?

ILiAD Biotechnologies LLC's official website is iliadbio.com


What is ILiAD Biotechnologies LLC's revenue?

ILiAD Biotechnologies LLC's annual revenue is $4.1 M.


What is ILiAD Biotechnologies LLC's SIC code?

ILiAD Biotechnologies LLC's SIC: 283; 28


What is ILiAD Biotechnologies LLC's NAICS code?

ILiAD Biotechnologies LLC's NAICS: 5417; 541.


How many employees does ILiAD Biotechnologies LLC's have?

ILiAD Biotechnologies LLC has 13 employees


What industry does ILiAD Biotechnologies LLC belong to?

ILiAD Biotechnologies LLC is in the industry of Biotechnology.

Next step

Visitors review